Items tagged with Drug-resistant TB
Fool’s errand: The sloppy science of the MDR-TB STREAM trial (post with simple image)
Confirming the efficacy and safety of bedaquiline-inclusive regimens is a priority. Comparing them to unvalidated MDR-TB drug combinations in the planned STREAM study is not the way to go about it.
Long walk to treatment for XDR tuberculosis in South Africa (post with simple image)
South Africa has about 18% of the global burden of laboratory-confirmed MDR tuberculosis and the highest number of confirmed XDR cases.
New tuberculosis drug regimen will move to landmark Phase 3 clinical trial (post with simple image)
STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB.
South Africa: "This disease is for heroes. If you can fight this, you can stand anything in this world" (post with simple image)
Siyabulela Qwaka is the latest patient cured of drug resistant TB in MSF’s project in Khayelitsha, South Africa. His story is an inspiration for the others currently fighting the new form of tuberculosis against which existing drugs are of limited effectiveness.
WHO’s first global report on antibiotic resistance reveals serious, worldwide threat to public health (post with simple image)
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries, including information on resistance to medicines for treating HIV, malaria and tuberculosis.
Otsuka wins European marketing authorization for Deltyba™ (delamanid) (post with simple image)
Deltyba has been granted a marketing authorization for use as part of an appropriate combination regimen for MDR-TB in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
Quantifying the tuberculosis disease burden in children (post with simple image)
A study estimates that 999 792 children developed TB in 2010, of whom 31 948 had MDR-TB. This value is nearly double the 530 000 paediatric cases estimated by WHO to have occurred in 2012.
UNITAID approves grants of $160 million (post with simple image)
Breakthrough new medicines for drug-resistant TB to be made available for low- and middle-income countries as part of $160 million of new grants funded by UNITAID.
‘We demand action’: Death toll from drug-resistant tuberculosis must be slashed within a year (post with simple image)
Phumeza Tisile, co-author of the DR-TB Manifesto and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide.
Otsuka and the WHO’s Global Laboratory Initiative (GLI) launch new laboratory manual (post with simple image)
23 May 2014 - Otsuka and the WHO’s Global Laboratory Initiative (GLI) working group of the Stop TB Partnership launched a new Mycobacteriology Laboratory Manual at the GLI Annual Meeting on April 30th.
Page 93 of 117 · Total posts: 0
←First 92 93 94 Last→